Effects of bisoprolol in patients with stable congestive heart failure.
暂无分享,去创建一个
N. Lamblin | P. De Groote | C. Bauters | A. Millaire | P. Groote | P de Groote | A Millaire | P Delour | N Lamblin | J Dagorn | C Verkindère | E Tison | C Bauters | J. Dagorn | P. Delour | C. Verkindère | E. Tison | Christophe Bauters | Alain Millaire | Christine Verkindère
[1] Effect of carvedilol on survival in severe chronic heart failure. , 2001 .
[2] B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. , 2004, Journal of the American College of Cardiology.
[3] M. Metra,et al. Differential Effects of β-Blockers in Patients With Heart Failure , 2000 .
[4] M. Guazzi,et al. Carvedilol reduces the inappropriate increase of ventilation during exercise in heart failure patients. , 2002, Chest.
[5] Matthias Stuber,et al. Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging. , 2002, American heart journal.
[6] CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.
[7] K. Adams,et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. , 1996, Circulation.
[8] P. De Groote,et al. Plasma levels of endothelin-1 at rest and after exercise in patients with moderate congestive heart failure. , 1995, International journal of cardiology.
[9] H. Valantine,et al. Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. , 1989, Circulation.
[10] R. Quaife,et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. , 2002, The New England journal of medicine.
[11] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[12] J. A. Bowers,et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. , 1996, Circulation.
[13] D. DeMets,et al. Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.
[14] M. Hetzel,et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). , 1997, Circulation.
[15] J. Le Heuzey,et al. Effects of bisoprolol on heart rate variability in heart failure. , 1996, The American journal of cardiology.
[16] D. Renlund,et al. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. , 1995, Journal of the American College of Cardiology.
[17] P. De Groote,et al. Plasma levels of atrial natriuretic peptide at peak exercise: a prognostic marker of cardiovascular-related death and heart transplantation in patients with moderate congestive heart failure. , 1997, The Journal of Heart and Lung Transplantation.
[18] P. Grayburn,et al. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. , 1995, Journal of the American College of Cardiology.
[19] K. Swedberg,et al. Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.
[20] X Marchandise,et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. , 1998, Journal of the American College of Cardiology.
[21] M. Packer,et al. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. , 1998, Circulation.
[22] K. Swedberg,et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy , 1993, The Lancet.